Trial Profile
Effect of glimepiride on glycemic control in patients with typ 2 diabetes treated with insulin and metfromin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Oct 2012
Price :
$35
*
At a glance
- Drugs Glimepiride (Primary) ; Insulin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GLIM
- 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
- 01 Oct 2012 Primary endpoint 'Proportion-of-glycosylated-haemoglobin' has been met.
- 18 Jun 2011 New trial record